Fulcrum Therapeutics Inc.

$FULC is up around 45% at the moment and sitting right at its 200DMA, after the FDA announced that it was lifting a hold on the company’s sickle-cell disease drug FTX-6058

Share This Article

 

About the Author

Fulcrum Therapeutics Inc.

Joey Ramson